Through our partnership with IDT, Scientia Link delivers a comprehensive portfolio of advanced genomics solutions—supporting the full spectrum of cancer and genetic research. Our offerings enable:
Cancer identification and tumor profiling
Whole-exome and whole-genome analysis
Comprehensive cancer research sequencing workflows
Biomarker discovery and validation
Liquid biopsy and NGS-based MRD research
Rare and inherited genetic disease investigations
In biomarker discovery, we further enhance market capabilities through our collaboration with SepSolve Analytical. By monitoring subtle changes in volatile organic compounds (VOCs) produced by the human body, SepSolve’s GC×GC-TOF-MS platforms offer a powerful approach for detecting, diagnosing, and tracking disease progression.
Together, these integrated technologies provide researchers, clinicians, and laboratories with high-precision tools for next-generation oncology, precision medicine, and translational research.
Scientia Link - Copyright . All rights reserved.
Contact Our Agents For Any kind of Business Requests
